[Federal Register Volume 83, Number 94 (Tuesday, May 15, 2018)]
[Notices]
[Pages 22532-22534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10273]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-609; NRC-2013-0235]
Northwest Medical Isotopes, LLC; Medical Radioisotope Production
Facility
AGENCY: Nuclear Regulatory Commission.
ACTION: Construction permit and record of decision; issuance.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC or the Commission)
is providing notice of the issuance of Construction Permit No. CPMIF-
002 to Northwest Medical Isotopes, LLC (NWMI) and record of decision
(ROD).
DATES: The construction permit was issued, and is immediately
effective, May 9, 2018.
ADDRESSES: Please refer to Docket ID NRC-2013-0235 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly-available information related to this document
using any of the following methods:
Federal Rulemaking Website: Go to http://www.regulations.gov and search
[[Page 22533]]
for Docket ID NRC-2013-0235. Address questions about NRC dockets to
Jennifer Borges; telephone: 301-287-9127; email:
[email protected]. For technical questions, contact the
individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209 or 301-415-4737, or by email to [email protected].
For the convenience of the reader, the ADAMS accession numbers are
provided in a table in the ``Availability of Documents'' section of
this document.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2856; email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Introduction
Under section 2.106 of title 10 of the Code of Federal Regulations
(10 CFR), the NRC is providing notice of the issuance of Construction
Permit No. CPMIF-002 to NWMI and the issuance of the ROD under 10 CFR
51.102(c). The construction permit, which is immediately effective,
authorizes NWMI to construct a 10 CFR part 50 production facility
designed for the production of medical radioisotopes in Columbia,
Missouri, as described in NWMI's application for a construction permit
and in evidence received at the mandatory hearing held by the
Commission. With respect to the application for the construction permit
filed by NWMI, the NRC finds that the applicable standards and
requirements of the Atomic Energy Act of 1954, as amended, and the
Commission's regulations have been met. The NRC finds that any required
notifications to other agencies or bodies have been duly made and that,
among other things, there is reasonable assurance that the activities
authorized by the permit will be conducted in compliance with the rules
and regulations of the Commission, that safety questions will be
satisfactorily resolved by the completion of construction, and that,
taking into consideration siting criteria, the proposed facility can be
constructed and operated at the proposed location without undue risk to
the public health and safety, subject to the conditions listed in the
construction permit. Furthermore, the NRC finds that the licensee is
technically and financially qualified to engage in the activities
authorized, and that issuance of the license will not be inimical to
the common defense and security or to the health and safety of the
public. Finally, the NRC finds that the findings required by subpart A
of 10 CFR part 51 have been made.
II. Further Information
The NRC prepared a safety evaluation report and a final
environmental impact statement that document the information reviewed
and the NRC's conclusions. The Commission also issued its Memorandum
and Order (CLI-18-06), documenting its final decision on the mandatory
hearing held on January 23, 2018, which serves as the ROD in this
proceeding. The Commission's final decision authorized the issuance of
the construction permit for the NWMI medical radioisotope production
facility, contingent upon the inclusion of a revised safety permit
condition. The NRC also prepared a document summarizing the ROD to
accompany its action on the construction permit application that
incorporates by reference materials contained in the final
environmental impact statement. In accordance with 10 CFR 2.390 of the
NRC's ``Agency Rules of Practice and Procedure,'' details with respect
to this action, including the safety evaluation report, final
environmental impact statement, summary ROD, and accompanying
documentation included in the construction permit package, as well as
the Commission's hearing decision and ROD, are available online in the
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. From this site, persons can access the NRC's ADAMS, which
provides text and image files of NRC's public documents. In addition,
prior to its publication as a NUREG document, the NRC staff will update
the safety evaluation report to reflect the revised permit condition.
III. Availability of Documents
The documents identified in the following table are available to
interested persons through one or more of the following methods, as
indicated.
------------------------------------------------------------------------
Document ADAMS Accession No.
------------------------------------------------------------------------
Construction Permit No. CPMIF-002...... ML18037A308
Commission's Memorandum and Order ML18123A374
(CLI[dash]18-06) on the Mandatory
Hearing (ROD).
Summary of the Record of Decision...... ML18053A074
Safety Evaluation Report Related to the ML18016A021
Northwest Medical Isotopes, LLC
Construction Permit Application for a
Production Facility.
NUREG-2209, ``Environmental Impact ML17130A862
Statement for the Construction Permit
for the Northwest Medical Isotopes
Radioisotope Production Facility:
Final Report''.
NWMI Construction Permit Application... ML15210A182
ML17257A019
------------------------------------------------------------------------
[[Page 22534]]
Dated at Rockville, Maryland, this 9th day of May 2018.
For the Nuclear Regulatory Commission.
Anita L. Lund,
Director, Division of Licensing Projects, Office of Nuclear Reactor
Regulation.
[FR Doc. 2018-10273 Filed 5-14-18; 8:45 am]
BILLING CODE 7590-01-P